| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Silverback Therapeutics, Inc. | Sr. Vice President of Finance | Common Stock | 37,251 | $140,921 | $3.78 | 02 May 2022 | Direct |
| Silverback Therapeutics, Inc. | Sr. Vice President of Finance | Stock Option (right to buy) | 56,670 | 02 May 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SPRY | Silverback Therapeutics, Inc. | 02 May 2022 | 2 | $0 | 4 | Sr. Vice President of Finance | 04 May 2022, 17:00 |
| SPRY | Silverback Therapeutics, Inc. | 01 Feb 2022 | 3 | $0 | 4 | Sr. Vice President of Finance | 02 Feb 2022, 16:22 |
| SPRY | Silverback Therapeutics, Inc. | 08 Dec 2020 | 1 | +$4,200 | 4/A | Sr. Vice President of Finance | 24 Feb 2022, 18:55 |